(Q45757472)

15 December 2017

title

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity (English)

1 reference

15 December 2017

1 reference

1 reference

1 reference

12

Poynard T

1 reference

15 December 2017

Mathurin P

1

1 reference

15 December 2017

Moussalli J

2

1 reference

15 December 2017

Cadranel JF

3

1 reference

15 December 2017

Thibault V

4

1 reference

15 December 2017

Charlotte F

5

1 reference

15 December 2017

Dumouchel P

6

1 reference

15 December 2017

Cazier A

7

1 reference

15 December 2017

Huraux JM

8

1 reference

15 December 2017

Devergie B

9

1 reference

15 December 2017

Vidaud M

10

1 reference

15 December 2017

Opolon P

11

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

15 December 2017

published in

Hepatology

1 reference

15 December 2017

volume

27

1 reference

15 December 2017

page(s)

868-872

1 reference

15 December 2017

issue

3

1 reference

15 December 2017

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270333

7 January 2021

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270333

7 January 2021

Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270333

7 January 2021

Neutrophil activation in chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270333

7 January 2021

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270333

7 January 2021

Persistent hepatitis C viraemia without liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270333

7 January 2021

Histological findings in asymptomatic hepatitis C virus carriers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270333

7 January 2021

Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270333

7 January 2021

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270333

7 January 2021

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270333

7 January 2021

Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270333

7 January 2021

Identifiers

DOI

10.1002/HEP.510270333

1 reference

15 December 2017

PubMed ID

9500720

1 reference

15 December 2017